SNAI3 and hepatocellular carcinoma: We first reported that the high expression of SNAI3‐AS1 in HCC, and combined with the clinical and pathological characteristics of HCC patients, we determined that high SNAI3‐AS1 expression was significantly associated with tumour sizes and TNM stage.